tanios bekaii-saab, md: clinical data supporting trifluradine-tipiracil
Published 8 years ago • 23 plays • Length 1:40
Download video MP4
Download video MP3
Similar videos
-
1:20
tanios bekaii-saab, md: clinical data supporting regorafenib in mcrc
-
0:46
tara seery, md: clinical data supporting trifluradine-tipiracil
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
4:32
tanios bekaii-saab, md: cost issues with ct regimens and bevacizumab
-
2:02
tanios bekaii-saab, md: impact of third-line therapy
-
0:26
tanios bekaii-saab, md: ras mutations in metastatic colorectal cancer
-
2:17
tanios bekaii-saab, md: first-line treatments in unresectable colon cancer
-
3:50
case study of a 33-year-old with metastatic colorectal cancer
-
3:45
dr puntambekar, consultant oncologist, talks about versius
-
2:13
mr. buvanesvaran tachina moorthi - kanker & bedah kolorektal indonesian
-
1:27
tanios bekaii-saab, md: mutations in colorectal cancer
-
2:56
tanios bekaii saab, md: treatment toxicities and quality of life
-
0:28
tanios bekaii-saab, md: reinitiating regorafenib in patients with mcrc
-
1:21
tanios bekaii-saab, md: regorafenib dose adjustments
-
2:22
dr. tanios bekaii-saab on new agents to treat colorectal cancer
-
2:19
tanios bekali-saab, md, on utilizing regorafenib (stivarga) and trifluridine (lonserf)
-
1:07
what are the treatment options for colorectal cancer? - dr. tanios bekaii-saab
-
1:27
tanios bekaii-saab, md, comments on dosing regorafenib (stivarga) in 3rd line treatment of mcrc
-
6:43
tanios bekaii-saab md, facp, discusses changes in treatment for crc patients resulting from covid-19
-
3:31
tanios bekaii-saab md, facp describes deintensification strategies for mcrc patients during covid-19
-
3:16
tanios bekaii-saab, md, discusses oral chemo in adjuvant and advanced crc treatment during covid
-
1:30
tanios bekaii-saab, md on msi-high as an mcrc response predictor to nivolumab (opdivo)
Clip.africa.com - Privacy-policy